ELSP Apr 28 2026 A recent review shows that proteomics-driven multi-omics integration reveals tumor heterogeneity and functional regulatory networks beyond genomic information, facilitating the discovery of clinically relevant biomarkers and therapeutic targets. Emerging single-cell and spatial proteomics technologies, together with AI-driven analysis, offer new opportunities to advance precision oncology. Cancer is a highly complex and dynamic biological system in which molecular regulation